This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Qbiotics Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Katja Etel Hill: Innovator in Biofilm Disruption and Antifungal Applications
Introduction
Katja Etel Hill is a notable inventor based in Cardiff, GB. She is currently associated with Algipharma AS, where she focuses on innovative solutions in the field of biofilm disruption and antifungal treatments. Despite having no granted patents to her name, her contributions to the field are significant and reflect her dedication to advancing medical science.
Latest Patent Applications
Katja's latest patent applications include two noteworthy inventions. The first is titled "Biofilm Disruption," which relates to methods of dispersing biofilms comprising Gram-negative bacteria. This invention involves exposing the biofilm to an epoxytiglienone compound or a salt thereof. It also describes methods for treating infections through localized administration of the compound to disrupt established biofilms on medical devices.
The second application is "Use of Alginate Oligomers to Enhance the Effects of Antifungal Agents." This disclosure focuses on using alginate oligomers to improve the efficacy of antifungal agents against fungi. The method can be applied to both animate and inanimate surfaces, providing solutions for medical and non-medical uses.
Conclusion
Katja Etel Hill is an innovative inventor whose work in biofilm disruption and antifungal applications holds promise for future advancements in medical treatments. Her research reflects a commitment to improving health outcomes through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile